Cardinal Health Management

Management criteria checks 0/4

Cardinal Health's CEO is Jason Hollar, appointed in Sep 2022, has a tenure of 1.75 years. total yearly compensation is $18.78M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 0.018% of the company’s shares, worth $4.68M. The average tenure of the management team and the board of directors is 1.8 years and 2.8 years respectively.

Key information

Jason Hollar

Chief executive officer

US$18.8m

Total compensation

CEO salary percentage6.6%
CEO tenure1.8yrs
CEO ownership0.02%
Management average tenure1.8yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056

Jun 11
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056

Cardinal Health's Valuation Makes The Name Unattractive

May 26

Cardinal Health Q3 Earnings: Undervalued On Strong Guidance

May 03

Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Apr 14
Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Mar 09
Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration

Feb 20

Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Feb 03
Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues

Dec 28
Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues

Cardinal Health Is Setting Up For A Great 2024

Dec 21

Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Nov 03
Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity

Oct 13

Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation

Aug 07

Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue

Aug 05
Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue

An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued

Jul 14
An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued

Cardinal Health: Not A Long-Term Investment

May 24

The Return Trends At Cardinal Health (NYSE:CAH) Look Promising

Apr 17
The Return Trends At Cardinal Health (NYSE:CAH) Look Promising

Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price

Mar 30
Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price

Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)

Feb 21

Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957

Feb 16
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957

Cardinal Health declares $0.4957 dividend

Feb 10

Cardinal Health FQ2 2023 Earnings Preview

Feb 01

Cardinal Health partners with Palantir for data-driven supply chain support

Jan 26

Cardinal Health Is A Tempting Healthcare Income Play

Dec 28

Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957

Dec 20
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957

Aaron Alt is the new finance chief at Cardinal health

Dec 19

Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?

Dec 14
Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?

Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Nov 16
Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment

Nov 14

Cardinal Health rises on Q1 earnings beat

Nov 04

Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term

Oct 10

Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Sep 29
Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Cardinal Health: Aristocrat Heading For A Makeover

Sep 26

PayrHealth to collaborate with Cardinal Health

Sep 15

Cardinal Health in pact with activist investor Elliot for value creation measures

Sep 06

Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957

Sep 01
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957

Activist interest in Cardinal Health could unlock value, improve margins - Morgan Stanley

Aug 16

Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?

Aug 15
Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?

CEO Compensation Analysis

How has Jason Hollar's remuneration changed compared to Cardinal Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$552m

Dec 31 2023n/an/a

US$639m

Sep 30 2023n/an/a

US$156m

Jun 30 2023US$19mUS$1m

US$261m

Mar 31 2023n/an/a

US$463m

Dec 31 2022n/an/a

-US$1b

Sep 30 2022n/an/a

-US$1b

Jun 30 2022US$4mUS$729k

-US$933m

Mar 31 2022n/an/a

-US$955m

Dec 31 2021n/an/a

US$555m

Sep 30 2021n/an/a

US$1b

Jun 30 2021US$4mUS$700k

US$611m

Mar 31 2021n/an/a

US$1b

Dec 31 2020n/an/a

US$1b

Sep 30 2020n/an/a

US$973m

Jun 30 2020US$4mUS$124k

-US$4b

Compensation vs Market: Jason's total compensation ($USD18.78M) is above average for companies of similar size in the US market ($USD13.50M).

Compensation vs Earnings: Jason's compensation has increased by more than 20% in the past year.


CEO

Jason Hollar (51 yo)

1.8yrs

Tenure

US$18,776,433

Compensation

Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...


Leadership Team

NamePositionTenureCompensationOwnership
Jason Hollar
CEO & Director1.8yrsUS$18.78m0.018%
$ 4.7m
Aaron Alt
Chief Financial Officer1.3yrsUS$6.00m0.00095%
$ 240.9k
Jessica Mayer
Chief Legal & Compliance Officer5.3yrsUS$4.40m0.016%
$ 3.9m
Stephen Mason
Chief Executive Officer of Medical Segment4.8yrsUS$4.42m0.0023%
$ 578.0k
Deborah Weitzman
Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment1.8yrsUS$4.07m0.014%
$ 3.6m
Patricia English
Senior Vice President1.3yrsUS$1.26m0.0020%
$ 514.7k
Mary Scherer
Senior VP & Chief Accounting Officer1.8yrsno data0.0043%
$ 1.1m
Michelle Greene
Executive VP1.8yrsno data0.0080%
$ 2.0m
Matt Sims
Vice President of Investor Relationsno datano datano data
Ola Snow
Chief Human Resources Officer5.7yrsno data0.010%
$ 2.6m
Craig Cowman
Executive Vice President of Biopharma Solutions & Strategic Sourcingno datano datano data
Ben Brinker
President of Global Products & Supply Chain3.3yrsno datano data

1.8yrs

Average Tenure

52.5yo

Average Age

Experienced Management: CAH's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jason Hollar
CEO & Director1.8yrsUS$18.78m0.018%
$ 4.7m
Gregory Kenny
Independent Non-Executive Chairman16.8yrsUS$553.58k0%
$ 0
Christine Ann Mundkur
Independent Director1.8yrsUS$310.03k0%
$ 0
Patricia Hemingway Hall
Independent Director10.8yrsUS$320.03k0.0045%
$ 1.1m
David Evans
Independent Director3.9yrsUS$302.03k0%
$ 0
Sheri Edison
Independent Director3.8yrsUS$319.95k0.0017%
$ 423.4k
Nancy Killefer
Independent Director8.8yrsUS$300.03k0%
$ 0
Akhil Johri
Independent Director6.3yrsUS$325.03k0%
$ 0
Sujatha Chandrasekaran
Independent Director1.8yrsUS$310.03k0%
$ 0
Steven Barg
Independent Director1.8yrsUS$310.03k0.00019%
$ 48.2k
Robert Azelby
Independent Directorless than a yearno datano data
Michelle Brennan
Independent Director1.8yrsUS$310.03k0.00023%
$ 58.3k

2.8yrs

Average Tenure

61yo

Average Age

Experienced Board: CAH's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.